...
首页> 外文期刊>Trials >Non-invasive ventilation for the management of children with bronchiolitis (NOVEMBR): a feasibility study and core outcome set development protocol
【24h】

Non-invasive ventilation for the management of children with bronchiolitis (NOVEMBR): a feasibility study and core outcome set development protocol

机译:无创通气治疗儿童毛细支气管炎(NOVEMBR):可行性研究和核心结局开发方案

获取原文
           

摘要

Bronchiolitis is an acute lower respiratory infection which predominantly affects young children. Treatment for bronchiolitis is limited to supportive therapy. Nasal oxygen therapy is part of routine care, and delivery now incorporates varying levels of non-invasive continuous positive airway pressure and/or high-flow nasal cannula oxygen therapy. Despite wide clinical use, there remains a lack of evidence on the comparative effectiveness and safety of these interventions. Furthermore, research in this field is hampered by the use of multiple outcome measures in current clinical trials. This mixed methods study includes a systematic review of outcome measures, telephone interviews with parents, focus group workshops and a Delphi survey with healthcare professionals and parents. These methods will be used to identify and prioritise outcomes for inclusion in a core outcome set and to explore issues pertinent to the design of a future randomised controlled trial comparing different modes of oxygen therapy for bronchiolitis. UK hospitals will also be contacted and asked to complete a survey to provide an overview of current practice to enable assessment of capability and capacity to run a future clinical trial. This study will facilitate the design of a future clinical trial of non-invasive ventilation in children with bronchiolitis which is acceptable to important stakeholders. Furthermore, core outcome set development will improve standardisation, measurement and reporting of clinically important outcomes in bronchiolitis. ISRCTN Registry, ISRCTN75766048. Registered on 18 December 2017. This study was retrospectively registered in the ISRCTN Registry and on the Core Outcome Measures in Effectiveness Trials (COMET) Initiative database (15 September 2017).
机译:细支气管炎是一种急性下呼吸道感染,主要影响幼儿。毛细支气管炎的治疗仅限于支持疗法。鼻氧疗法是常规护理的一部分,现在分娩采用了不同水平的非侵入性连续气道正压和/或高流量鼻导管氧疗法。尽管临床上已广泛使用,但仍缺乏有关这些干预措施的相对有效性和安全性的证据。此外,该领域的研究由于当前临床试验中使用多种结果指标而受到阻碍。这项混合方法研究包括对结局指标的系统评价,与父母的电话访谈,焦点小组研讨会以及与医疗保健专业人员和父母进行的德尔福调查。这些方法将用于确定结果并确定结果的优先次序,以纳入核心结果集中,并探讨与设计未来的随机对照试验设计相关的问题,该试验比较了不同的细支气管炎氧疗方式。还将联系英国医院并要求他们完成一项调查,以概述当前的实践,以评估进行未来临床试验的能力。这项研究将有助于未来细支气管炎患儿无创通气临床试验的设计,这是重要的利益相关者可以接受的。此外,核心结果集的开发将改善毛细支气管炎临床重要结果的标准化,测量和报告。 ISRCTN注册中心,ISRCTN75766048。这项研究于2017年12月18日注册。该研究已在ISRCTN注册中心和有效性试验核心成果措施(COMET)计划数据库(2017年9月15日)中进行了回顾性注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号